Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs SharkNinja Inc. Ordinary Shares (SN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs SharkNinja Inc. Ordinary Shares — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while SharkNinja Inc. Ordinary Shares trades at $186 (market cap $26.60B). The key difference: SharkNinja Inc. Ordinary Shares is far larger — about 27.3× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and SharkNinja Inc. Ordinary Shares is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and SharkNinja Inc. Ordinary Shares for 3 Days on average.
| MRVI | SN | |
|---|---|---|
Market Cap | $972.90M | $26.60B |
Volume | 4,325,710 | 1,030,578 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.00 | $192.86 |
52-Week Low | $2.83 | $84.57 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $1.08B | $26.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
SharkNinja (SN) trades at $188.80, down 0.62% with a bullish technical outlook supported by moving averages. The company demonstrates strong fundamentals with consistent earnings beats, 10.06% net margin, and robust cash flow growth. Recent product launches including new vacuum and kitchen systems highlight ongoing innovation. Analyst sentiment remains overwhelmingly positive with 91% buy ratings and a $202.18 consensus target.
SN presents a compelling growth story with strong profitability and product momentum, though elevated P/E of 38.5 suggests premium valuation. Key risks include consumer spending sensitivity and competitive pressures in home appliances. The stock's proximity to resistance at $192 requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About SharkNinja Inc. Ordinary Shares
SharkNinja designs and sells small household appliances under the Shark and Ninja brands. Its products include cleaning appliances, kitchen and beverage appliances, food preparation products, and beauty and home-environment devices.
Read more on SN →
